disopyramide has been researched along with Pain in 3 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Disopyramide is a new antiarrhythmic drug with a pharmacological profile of action similar to that of quinidine and procainamide." | 6.36 | Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| "Disopyramide is a new antiarrhythmic drug with a pharmacological profile of action similar to that of quinidine and procainamide." | 2.36 | Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| "SUN 1165 had no effect on clonic convulsions induced by pentetrazol and pictrotoxin in mice, while both mexiletine and lidocaine prolonged the duration of clonic convulsions." | 1.27 | General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system. ( Hashimoto, Y; Hatta, M; Hattori, Y; Hirotsu, I; Ishihara, T; Kihara, T; Kitakaze, Y; Miyata, T; Nakamura, S; Takahama, K, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heel, RC | 1 |
| Brogden, RN | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Manolas, EG | 1 |
| Hunt, D | 1 |
| Dowling, JT | 1 |
| Luxton, M | 1 |
| Vohra, J | 1 |
| Hirotsu, I | 1 |
| Kihara, T | 1 |
| Nakamura, S | 1 |
| Hattori, Y | 1 |
| Hatta, M | 1 |
| Kitakaze, Y | 1 |
| Takahama, K | 1 |
| Hashimoto, Y | 1 |
| Miyata, T | 1 |
| Ishihara, T | 1 |
1 review available for disopyramide and Pain
| Article | Year |
|---|---|
Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Disopyramide; Drug Interactions; Electrophysiology; Heart; Hemodynamics; Human | 1978 |
2 other studies available for disopyramide and Pain
| Article | Year |
|---|---|
Collapse after oral administration of disopyramide.
Topics: Abdomen; Arrhythmias, Cardiac; Disopyramide; Humans; Hypotension; Pain; Pyridines; Venous Pressure | 1979 |
General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Body Temperature; Catalepsy; Cats; Central Ne | 1988 |